Main menu

London Calling 2023: Targeted nanopore sequencing using hybridisation probes reveals immune escape polymorphisms in malaria vaccine candidates


Pathogen populations exposed to host immunity acquire and maintain variation in surface proteins to escape immune responses and contribute to the incomplete efficacy of vaccines. The malaria parasite, Plasmodium falciparum is responsible for over 600,000 deaths and over 400 million clinical episodes of malaria each year. To investigate variation in P. falciparum antigen genes being investigated as vaccine candidates, we developed a nanopore sequencing approach using custom hybridisation probes and an automated haplotype-aware single nucleotide variant (SNV) calling pipeline. This method was applied to investigate SNVs associated with immune escape by sequencing 34 antigen genes in a cohort of children from malaria-endemic areas of Papua New Guinea. Blood-stage antigens were more likely to contain immune-escape polymorphisms than antigens expressed in other lifecycle stages. Identification of these SNVs, associated haplotypes and their prevalence allows recommendations for the formulation of the next generation of P. falciparum vaccines based on diverse antigens.

Authors: Alyssa Barry

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

ナノポア技術

ナノポアの最新ニュースを購読 リソースと発表文献 Nanopore Communityとは

Oxford Nanoporeについて

ニュース 会社沿革 持続可能性 経営陣 メディアリソース & お問い合わせ先 投資家向け パートナー向け Oxford Nanopore社で働く 現在の募集状況 営業上の情報 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag